[
    [
        {
            "time": "",
            "original_text": "康龙化成(300759.SZ)：第三季度净利预增42%-62%",
            "features": {
                "keywords": [
                    "康龙化成",
                    "第三季度",
                    "净利预增",
                    "42%-62%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(300759.SZ)：第三季度净利预增42%-62%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "部分CRO&CDMO三季度业绩预告出炉，业绩分化明显 盈利能力下降",
            "features": {
                "keywords": [
                    "CRO",
                    "CDMO",
                    "三季度",
                    "业绩分化",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "部分CRO&CDMO三季度业绩预告出炉，业绩分化明显 盈利能力下降",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【康龙化成】19Q3预告点评：业绩显著超预期，协同效应效果显著",
            "features": {
                "keywords": [
                    "康龙化成",
                    "19Q3",
                    "业绩显著超预期",
                    "协同效应",
                    "效果显著"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【康龙化成】19Q3预告点评：业绩显著超预期，协同效应效果显著",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]